Jpmorgan Chase & Co »

Palvella Therapeutics Inc Ne shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $272k 4.3k 62.69
2025-03-31 $84 3 28.00
2024-12-31 $312 26 12.00

More positions owned by Jpmorgan Chase & Co

Nvidia Corporation Common (NVDA)
Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Meta Platforms Common (META)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Broadcom Common (AVGO)
Alphabet Common (GOOG)
Tesla Common (TSLA)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Vanguard S&p 500 Etf Fund (VOO)
Ishares Core S&p 500 Etf Fund (IVV)
Oracle Corp Common (ORCL)
Abbvie Common (ABBV)

View all positions for Jpmorgan Chase & Co

Top funds holding Palvella Therapeutics Inc Ne

BVF
Suvretta Capital Management
Frazier Life Sciences Management
First Light Asset Management
Vanguard Group
BlackRock
State Street Corporation
Perceptive Advisors
Summit Partners Public Asset Management
Jennison Associates
Federated Investors
Woodline Partners
Artisan Partners Limited Partnership
MPM Oncology Impact Management
Caption Management

View all funds holding Palvella Therapeutics Inc Ne